Transsphenoidal hypophysectomy in disseminated breast cancer

Area of Science:

• Oncology
• Neurosurgery
• Endocrinology

Background:

• Metastatic breast cancer presents significant challenges in patient management and quality of life.
• Palliative care options for advanced breast cancer aim to improve survival and alleviate symptoms like pain.

Purpose of the Study:

• To evaluate the efficacy and safety of transsphenoidal hypophysectomy in patients with advanced breast cancer.
• To assess the impact of this surgical intervention on survival rates and pain management.

Main Methods:

• A cohort of sixty patients with metastatic breast cancer underwent transsphenoidal hypophysectomy.
• Patient outcomes, including survival duration, pain relief, and operative complications, were retrospectively analyzed.

Main Results:

• Median survival for the entire group was ten months.
• Good responders demonstrated significantly longer survival (over 14 months) compared to nonresponders (three months).
• The majority of patients with severe pain experienced significant relief; operative complications were minimal.

Conclusions:

• Transsphenoidal hypophysectomy is a viable palliative option for advanced breast cancer, offering objective and subjective benefits.
• The procedure is associated with minimal morbidity and can lead to improved survival, particularly in selected patient groups.